Publication:
Another adverse effect of vemurafenib: Gingival hyperplasia

Simple item page
dc.contributor.authorSALMAN, ANDAÇ
dc.contributor.authorYUMUK, PERRAN FULDEN
dc.contributor.authorERGUN, SAFİYE ATLAS TÜLİN
dc.contributor.authorsSalman, Andac; Tekin, Burak; Koca, Sinan; Akgul Babacan, Nalan; Yumuk, Perran Fulden; Ergun, Tulin
dc.date.accessioned2022-03-15T11:24:36Z
dc.date.accessioned2026-01-11T17:14:47Z
dc.date.available2022-03-15T11:24:36Z
dc.date.issued2016
dc.identifier.doi10.1111/1346-8138.13248
dc.identifier.issn1346-8138
dc.identifier.pubmedPMID: 26703083
dc.identifier.urihttps://hdl.handle.net/11424/250153
dc.language.isoeng
dc.relation.ispartofThe Journal of Dermatology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAdult
dc.subjectHumans
dc.subjectMale
dc.subjectAntineoplastic Agents
dc.subjectIndoles
dc.subjectGingival Hyperplasia
dc.subjectSulfonamides
dc.subjectMelanoma
dc.subjectVemurafenib
dc.titleAnother adverse effect of vemurafenib: Gingival hyperplasia
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage707
oaire.citation.startPage706
oaire.citation.titleThe Journal of Dermatology
oaire.citation.volume6

Files

Collections

Araştırma Çıktıları